Senate OKs making synthetic drug '25I' controlled substance

AUSTIN, Texas (AP) - The Texas Senate has approved making the synthetic drug 25I-NBOMe a controlled substance, potentially banning it from being sold online and in places like convenience stores.

Originally developed as a research tool for scientists, so-called "25I" has psychedelic effects that mimic LSD.

State Sen. Joan Huffman, the bill's author, says 25I overdoses have killed or hospitalized teens in many parts of Texas.

Tuesday's 31-0 vote sends the measure to the House, where it's likely to draw strong support. Huffman said a similar bill passed the Senate in 2013 but died in the House because of what she called "vindictive" opposition from a representative who opposed Huffman on another issue.

Also Tuesday, the Senate approved and sent to the House two bills to limit synthetic marijuana production, distribution and use.

Copyright 2015 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.


  • Popular

  • Recent

WATCH FOX 7 NEWS LIVE

FOX 7 News streams at the following times (all times Central):


Monday - Friday

4:30 a.m. - 10 a.m.

12 p.m. - 12:30 p.m.

5 p.m. - 6 p.m.

9 p.m. - 10:30 p.m.

Saturday

6 a.m. - 8 a.m.

6 p.m. to 6:30 p.m.

9 p.m. to 10 p.m.

Sunday

6 a.m. - 8 a.m.

5 p.m. to 5:30 p.m.

9 p.m. to 10 p.m.



Schedule subject to change in the event of network sports coverage.

We also stream press conferences and other breaking news coverage from time to time. When we are not in a live newscast, you will see replays of the most recent broadcast.

To enter full screen Mode click the button.

For closed captioning, click on the button while in full screen mode.

Desktop/tablet users: To choose the stream's video quality, click on the button (while in full screen mode) and choose from 432p or 270p.

Mobile users:The video quality default is to your phone's settings.

Please allow time for buffering. If the stream stalls, refresh your browser. Thanks for watching

Stories You May Be Interested In - Includes Advertiser Stories